Drive Therapeutics
Chapel Hill
About Drive Therapeutics
Drive Therapeutics is a new biotechnology company that strives to improve treatment for retinal diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $431.0K
- Last round: Grant (Sep 2022)
- Website: drivetherapeutics.com
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/drive-therapeutics-692 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.